STRO — Sutro Biopharma Share News
0.000.00%
Last trade - 00:00- $154.70m
- $229.42m
- $102.48m
U.S. STOCKS ON THE MOVE-Tesla, Nike, Zynerba Pharmaceuticals
Brief: Sutro Biopharma To Provide Data Update On Stro-002 And Plans For Registrational Path Forward In Advanced Ovarian Cancer
Sutro Biopharma up on agreement with Vaxcyte for vaccine component
Brief: Sutro Biopharma And Vaxcyte Enter Into Option Grant Agreement For The Development And Manufacturing Rights Of Cell-Free Extract
Sutro Biopharma Inc reports results for the quarter ended in September - Earnings Summary
Brief: Sutro Biopharma Reports Third Quarter 2022 Financial Results
Sutro Biopharma Inc expected to post a loss of 74 cents a share - Earnings Preview
Brief: Sutro Biopharma Reports Second Quarter 2022 Financial Results, Business Highlights And Anticipated Milestones
Sutro Biopharma Inc reports results for the quarter ended in June - Earnings Summary
Brief: Sutro Biopharma Achieves 'First In Human' Milestone In Cytokine Derivatives Collaboration With Merck
U.S. RESEARCH ROUNDUP-Blue Bird, Lion Electric, Rev Group
U.S. STOCKS ON THE MOVE-Netflix, Playtika, Shopify, Li Auto
U.S. STOCKS ON THE MOVE-Walgreens Boots Alliance, Velodyne Lidar, U.S. banks
U.S. STOCKS ON THE MOVE-Snowflake, Nike, oil companies
Sutro Biopharma rises on cancer treatment deal with Japan's Astellas Pharma
Brief: Astellas And Sutro Biopharma Announce Worldwide Strategic Collaboration To Advance Novel Immunostimulatory Antibody-Drug Conjugates
Sutro Biopharma Inc reports results for the quarter ended in March - Earnings Summary
Brief: Sutro Biopharma Reports First Quarter 2022 Financial Results
Sutro Biopharma Inc expected to post a loss of 76 cents a share - Earnings Preview